Why the study?
Does incomplete revascularization (residual SYNTAX score ≥ 1) worsen outcomes compared to complete revascularization in patients with STEMI treated with primary PCI?
Does incomplete revascularization (residual SYNTAX score ≥ 1) worsen outcomes compared to complete revascularization in patients with STEMI treated with primary PCI?
Residual SYNTAX score ≥ 1 (incomplete revascularization) is associated with a higher incidence of recurrent MI and MACE in STEMI patients undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
rSS may aid post-STEMI risk stratification; leaves open its role in guiding revascularization decisions.
CĂle: PrognostickĂĄ hodnota reziduĂĄlnĂho SYNTAX skĂłre (rSS) byla popsĂĄna u rĹŻznĂ˝ch pacientskĂ˝ch populacĂ, tato jeho hodnota vĹĄak nebyla zjiĹĄĹĽovĂĄna u pacientĹŻ s infarktem myokardu s elevacemi Ăşseku ST (STEMI) lĂŠÄenĂ˝ch primĂĄrnĂ perkutĂĄnnĂ koronĂĄrnĂ intervencĂ (PCI).Metody: Do studie bylo zaĹazeno celkem 208 pacientĹŻ splĹujĂcĂch kritĂŠria vhodnosti k zaĹazenĂ. KompletnĂ revaskularizace (CR) byla definovĂĄna jako rSS = 0 a inkompletnĂ revaskularizace (IR) jako rSS s hodnotou ≥ 1.VĂ˝sledky: Z naĹĄeho vzorku pacientĹŻ jich bylo 78 (33,3 %) zaĹazeno do skupiny CR a 130 (67,7 %) do skupiny IR. Jeden pacient (1,3 %) ve skupinÄ CR a osm pacientĹŻ (6,2 %) ve skupinÄ IR zemĹelo do 30 dnĹŻ od zaĹazenĂ (p < 0,01). Incidence trombĂłzy stentu, recidivy infarktu myokardu (IM) a revaskularizace cĂlovĂŠ lĂŠze (target lesion revascularisation, TLR) byla v obou skupinĂĄch podobnĂĄ. BÄhem sledovĂĄnĂ (o prĹŻmÄrnĂŠ dĂŠlce 28,8 ± 7,1 mÄsĂce) zemĹeli dva pacienti (2,6 %) ze skupiny CR a deset pacientĹŻ (7,7 %) ze skupiny IR (p > 0,05). Incidence recidivy IM (18,5 % vs. 7,7 %; p < 0,01) a zĂĄvaĹžnĂ˝ch neŞådoucĂch kardiovaskulĂĄrnĂch pĹĂhod (major adverse cardiovascular events, MACE) (24,6 % vs. 7,7 %; p < 0,01) byla statisticky vĂ˝znamnÄ vyĹĄĹĄĂ ve skupinÄ IR.ZĂĄvÄr: Parametr rSS jako nepĹĂmĂ˝ ukazatel nekompletnĂ revaskularizace nezĂĄvisle koreloval s incidencĂ recidivy IM a MACE po STEMI.
No takes yet. Share an insight, caveat, or question.
Ösken et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: